A Deal Signed the Day Before the War: BioCatch Becomes a Unicorn

The company has completed a secondary deal of approximately $70 million with the Sapphire Fund at a value of more than $1 billion. This is the second major secondary transaction in the company from the beginning of 2023 after last May the investment fund Permira became the third largest shareholder after purchasing a package worth 40 million dollars from existing shareholders.